Belite Bio (BLTE) News Today $66.80 -2.68 (-3.86%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$67.05 +0.25 (+0.37%) As of 09/15/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLTE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Belite Bio (NASDAQ:BLTE) Given New $98.00 Price Target at HC Wainwright2 hours ago | americanbankingnews.comBelite Bio price target lowered to $98 from $100 at H.C. WainwrightSeptember 15 at 1:57 PM | msn.comBelite Bio (BLTE) Completes Phase 3 DRAGON Trial Enrollment For Stargardt TreatmentSeptember 13 at 2:44 PM | uk.finance.yahoo.comBelite Bio completes Phase 3 DRAGON trial of TinlarebantSeptember 12, 2025 | msn.comBelite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt DiseaseSeptember 12, 2025 | globenewswire.comBelite Bio (NASDAQ:BLTE) Shares Gap Up - Should You Buy?September 10, 2025 | marketbeat.comBelite Bio Secures $125 Million in PIPE Financing with Potential for MoreSeptember 9, 2025 | msn.comBelite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare InvestorsSeptember 8, 2025 | globenewswire.comAlyeska Investment Group L.P. Buys Shares of 83,623 Belite Bio, Inc. Sponsored ADR $BLTESeptember 8, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Shares Down 2.3% - Here's What HappenedSeptember 3, 2025 | marketbeat.comHC Wainwright Has Negative Outlook of Belite Bio Q3 EarningsAugust 16, 2025 | marketbeat.comQ3 EPS Estimates for Belite Bio Decreased by Leerink PartnrsAugust 16, 2025 | marketbeat.comBelite Bio FY2029 EPS Forecast Decreased by Leerink PartnrsAugust 15, 2025 | marketbeat.comBelite Bio to Participate in the H.C. Wainwright Annual Ophthalmology Virtual ConferenceAugust 13, 2025 | theglobeandmail.comBelite Bio’s Earnings Call: Progress Amid ChallengesAugust 13, 2025 | msn.comBelite Bio (NASDAQ:BLTE) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPSAugust 12, 2025 | marketbeat.comBelite Bio, Inc (BLTE) Q2 2025 Earnings Call TranscriptAugust 11, 2025 | seekingalpha.comBelite Bio, Inc 2025 Q2 - Results - Earnings Call PresentationAugust 11, 2025 | seekingalpha.comBelite Bio, Inc: Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate UpdateAugust 11, 2025 | finanznachrichten.deBelite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate UpdateAugust 11, 2025 | globenewswire.com1BLTE : Belite Bio's Earnings OutlookAugust 8, 2025 | benzinga.comBelite Bio Announces Registered Direct Offering of $15 MillionAugust 7, 2025 | globenewswire.comBelite Bio (NASDAQ:BLTE) Shares Up 0.3% - What's Next?August 2, 2025 | marketbeat.comBelite Bio (BLTE) Expected to Announce Earnings on FridayAugust 1, 2025 | marketbeat.comA Look At The Intrinsic Value Of Belite Bio, Inc (NASDAQ:BLTE)July 27, 2025 | finance.yahoo.comBelite Bio to Participate in the BTIG Virtual Biotechnology ConferenceJuly 25, 2025 | tmcnet.comBelite Bio Inc ADR News (BLTE) - Investing.comJuly 23, 2025 | investing.comBelite Bio (NASDAQ:BLTE) Sees Large Volume Increase - Should You Buy?July 15, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Shares Gap Down - What's Next?July 10, 2025 | marketbeat.comLeerink Partnrs Has Weak Estimate for Belite Bio Q2 EarningsJuly 10, 2025 | marketbeat.comLeerink Partnrs Comments on Belite Bio FY2029 EarningsJuly 9, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Sees Large Volume Increase - Here's What HappenedJuly 7, 2025 | marketbeat.comBelite Bio's (BLTE) "Buy" Rating Reaffirmed at HC WainwrightJuly 3, 2025 | marketbeat.comBelite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic AtrophyJuly 2, 2025 | globenewswire.comBelite Bio (NASDAQ:BLTE) Sees Large Volume Increase - Time to Buy?June 30, 2025 | marketbeat.comBelite Bio, Inc (NASDAQ:BLTE) Sees Large Growth in Short InterestJune 17, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Sees Unusually-High Trading Volume - Should You Buy?June 17, 2025 | marketbeat.comAnalysts Set Expectations for Belite Bio FY2026 EarningsJune 11, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Sees Unusually-High Trading Volume - Here's What HappenedJune 9, 2025 | marketbeat.comGAMMA Investing LLC Raises Stock Holdings in Belite Bio, Inc (NASDAQ:BLTE)June 9, 2025 | marketbeat.comBank of America Corp DE Acquires 4,891 Shares of Belite Bio, Inc (NASDAQ:BLTE)June 7, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Stock Price Down 4.1% - Here's WhyJune 6, 2025 | marketbeat.comBelite Bio, Inc (NASDAQ:BLTE) Short Interest Up 23.0% in MayJune 3, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Trading Up 5.3% - Should You Buy?May 30, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for Belite Bio Q1 Earnings?May 25, 2025 | marketbeat.comBelite Bio stock holds $80 target on FDA breakthrough nodMay 23, 2025 | investing.comBelite Bio (NASDAQ:BLTE) Shares Gap Up - Time to Buy?May 23, 2025 | marketbeat.comBelite Bio, Inc: Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt DiseaseMay 21, 2025 | finanznachrichten.deBelite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt DiseaseMay 21, 2025 | globenewswire.comFY2025 EPS Estimates for Belite Bio Cut by Cantor FitzgeraldMay 21, 2025 | marketbeat.com Get Belite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BLTE Media Mentions By Week BLTE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLTE News Sentiment▼0.680.94▲Average Medical News Sentiment BLTE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLTE Articles This Week▼93▲BLTE Articles Average Week Get the Latest News and Ratings for BLTE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Belite Bio and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies RVMD News GRFS News RYTM News LEGN News ABVX News RNA News CYTK News AXSM News NUVL News TGTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLTE) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Belite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLTE Stock Alerts